Given its role in repairing DNA damage, NER presents a potential therapeutic target. Compounds that inhibit NER could enhance the sensitivity of cancer cells to DNA-damaging agents, thereby improving the efficacy of chemotherapeutics. However, such approaches need to be carefully balanced to avoid unwanted side effects resulting from impaired DNA repair in normal cells.
